PropertyValue
nif:beginIndex
  • 0 (xsd:integer)
nif:broaderContext
nif:endIndex
  • 194 (xsd:integer)
nif:isString
  • To understand whether ECM3 cases could benefit from trastuzumab treatment, we analyzed the ECM signature in a cohort of patients treated in our institute with adjuvant trastuzumab-based therapy.
rdf:type